lithium 2,5-dimethyl-1-phenyl-1H-imidazole-4-carboxylate | 1261181-06-9

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: lithium 2,5-dimethyl-1-phenyl-1H-imidazole-4-carboxylate
• 英文别名: lithium;2,5-dimethyl-1-phenylimidazole-4-carboxylate
• CAS: 1261181-06-9
• 化学式: C₁₂H₁₁N₂O₂*Li
• 分子量: 222.173
• InChiKey: HUHNRIXXGYVFQZ-UHFFFAOYSA-M

计算性质

• 辛醇/水分配系数(LogP)：
  -2.14
• 重原子数：
  17
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.17
• 拓扑面积：
  58
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  2-(3-(4-(2,3-dichlorophenyl)piperazin-1-yl)-2-oxopropyl)isoindoline-1,3-dione 、 lithium 2,5-dimethyl-1-phenyl-1H-imidazole-4-carboxylate 在 N-甲基吗啉 、 1-羟基苯并三唑 、 盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 15.0h， 以40%的产率得到N-(3-(4-(2,3-dichlorophenyl)piperazin-1-yl)-2-hydroxypropyl)-2,5-dimethyl-1-phenyl-1H-imidazole-4-carboxamide
  参考文献：
  名称：

  [EN] NOVEL ARYLPIPERAZINE-CONTAINING IMIDAZOLE 4-CARBOXAMIDE DERIVATIVES AND PHARMACEUTICAL COMPOSITION COMPRISING SAME
  [FR] NOUVEAUX DÉRIVÉS IMIDAZOLE-4-CARBOXAMIDE CONTENANT DE L'ARYLPIPÉRAZINE ET COMPOSITION PHARMACEUTIQUE CONTENANT CES DÉRIVÉS

  摘要：

  公开号：

  WO2011005052A8
• 作为产物：
  描述：

  ethyl 2,5-dimethyl-1-phenyl-1H-imidazole-4-carboxylate 在 lithium hydroxide monohydrate 作用下， 以 四氢呋喃 、 水 为溶剂， 反应 12.0h， 以90%的产率得到lithium 2,5-dimethyl-1-phenyl-1H-imidazole-4-carboxylate
  参考文献：
  名称：

  [EN] NOVEL ARYLPIPERAZINE-CONTAINING IMIDAZOLE 4-CARBOXAMIDE DERIVATIVES AND PHARMACEUTICAL COMPOSITION COMPRISING SAME
  [FR] NOUVEAUX DÉRIVÉS IMIDAZOLE-4-CARBOXAMIDE CONTENANT DE L'ARYLPIPÉRAZINE ET COMPOSITION PHARMACEUTIQUE CONTENANT CES DÉRIVÉS

  摘要：

  公开号：

  WO2011005052A8

文献信息

• NOVEL ARYLPIPERAZINE-CONTAINING IMIDAZOLE 4-CARBOXAMIDE DERIVATIVES AND PHARMACEUTICAL COMPOSITION COMPRISING SAME
  申请人：Lee Jinhwa

  公开号：US20120115881A1

  公开（公告）日：2012-05-10

  A novel arylpiperazine-containing imidazole 4-carboxamide derivative or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition comprising the same as an active ingredient for preventing or treating a depressive disorder are provided.

  本发明提供了一种新的含有芳基哌嗪基的咪唑-4-羧酰胺衍生物或其药学上可接受的盐，并且提供了一种以其为活性成分的制药组合物，用于预防或治疗抑郁症。
• Arylpiperazine-containing imidazole 4-carboxamide derivatives and pharmaceutical composition comprising same
  申请人：Lee Jinhwa

  公开号：US08835436B2

  公开（公告）日：2014-09-16

  A novel arylpiperazine-containing imidazole 4-carboxamide derivative or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition comprising the same as an active ingredient for preventing or treating a depressive disorder are provided.

  本发明提供了一种新的含有芳基哌嗪基和咪唑-4-羧酰胺衍生物或其药学上可接受的盐，以及一种包含该衍生物作为活性成分的药物组合物，用于预防或治疗抑郁症。
• Design and Synthesis of Novel Arylpiperazine Derivatives Containing the Imidazole Core Targeting 5-HT_2A Receptor and 5-HT Transporter
  作者：Hee Jeong Seo、Eun-Jung Park、Min Ju Kim、Suk Youn Kang、Suk Ho Lee、Hyun Jung Kim、Ki Nam Lee、Myung Eun Jung、MinWoo Lee、Mi-Soon Kim、Eun-Jung Son、Woo-Kyu Park、Jeongmin Kim、Jinhwa Lee

  DOI：10.1021/jm200682b

  日期：2011.9.22

  Serotonin antagonist reuptake inhibitor (SARI) drugs that block both 5-HT2 receptors and the serotonin transporters have been developed. The human 5-HT2A/2C receptor has been implicated in several neurological conditions, and potent selective 5-HT2A/2C ligands may have therapeutic potential for treatment of CNS diseases such as depression. An imidazole moiety usually provides good pharmacokinetic properties as a drug substance, and thus considerable efforts have been devoted to develop imidazole derivatives into drug candidates. The imidazole series of compounds was evaluated against 5-HT2A/2C and serotonin reuptake inhibition. A few of the compounds in the series showed promising IC50 values and antidepressant-like effect in in vivo forced swimming test (FST). On the basis of these results, further lead optimization studies resulted in identifying promising compounds potentially for therapeutic use.
• US8835436B2
  申请人：——

  公开号：US8835436B2

  公开（公告）日：2014-09-16
• [EN] NOVEL ARYLPIPERAZINE-CONTAINING IMIDAZOLE 4-CARBOXAMIDE DERIVATIVES AND PHARMACEUTICAL COMPOSITION COMPRISING SAME<br/>[FR] NOUVEAUX DÉRIVÉS IMIDAZOLE-4-CARBOXAMIDE CONTENANT DE L’ARYLPIPÉRAZINE ET COMPOSITION PHARMACEUTIQUE CONTENANT CES DÉRIVÉS
  申请人：GREEN CROSS CORP

  公开号：WO2011005052A2

  公开（公告）日：2011-01-13

  A novel arylpiperazine-containing imidazole 4-carboxamide derivative or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition comprising the same as an active ingredient for preventing or treating a depressive disorder are provided.